Qube Research & Technologies (QRT)
SER icon

Qube Research & Technologies (QRT)’s Serina Therapeutics SER Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-404
Closed -$22K – 2493
2020
Q4 		$22K Buy
404
+41
+11% +$2.36K ﹤0.01% 1727
2020
Q3 		$10K Sell
363
-223
-38% -$7.96K ﹤0.01% 1592
2020
Q2 		$20K Buy
+586
New +$17.3K ﹤0.01% 1653

Other funds holding SER

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SWIG
Strategic Wealth Investment Group Louisville, Kentucky $788M AUM 14.6% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SER Position: Q1 2021 in Review

Qube Research & Technologies (QRT) sold out of Serina Therapeutics (SER) in Q1 2021, closing a stake of 404 shares — an estimated $22K sold.

Qube Research & Technologies (QRT) first reported a position in SER in Q2 2020 and held it in 3 quarters. The position peaked at $22K in Q4 2020. 36 funds tracked by Wall St. Rank hold SER as of Q1 2021.

  • Qube Research & Technologies (QRT) reported no remaining Serina Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 404 Serina Therapeutics shares in Q1 2021, an estimated $22K.
  • Qube Research & Technologies (QRT) first reported a position in Serina Therapeutics in Q2 2020 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Serina Therapeutics position peaked at $22K in Q4 2020.
  • 36 funds tracked by Wall St. Rank held Serina Therapeutics as of Q1 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2021, filed 14 May 2021.